European Society of Cardiology 1995 INR range | British Society of Haematology 1998 INR target | |
Mechanical valves* | ||
Aortic: | ||
First generation | 3.0-4.5 | 3.5 |
Second generation | 2.5-3.0 | 3.5† |
Third generation | 2.5-3.0 | 3.5† |
Mitral | 3.0-3.5 | 3.5 |
Bioprosthetic valves | ||
In sinus rhythm: | ||
Aortic | 2.5-3.0 for three months | No anticoagulation‡ |
Mitral | 3.0-3.5 for three months. No anticoagulation after three months | 2.5 for three months. No anticoagulation after three months |
In atrial fibrillation: | ||
Rheumatic valvar heart disease | 3.0-4.5 | 2.5 |
Patients with recurrent emboli under adequate anticoagulation | 3.0-4.5 + 100 mg aspirin | — |
Non-valvar atrial fibrillation with risk factors | 2.0-3.0 | 2.5 |